Exposure to ciprofloxacin and risk of musculoskeletal adverse events in children: a systematic review and meta-analysis of randomized controlled trials
Adverse Drug Reaction Bulletin · 2026-06 · 358 (1) · 1391-1394
DOI: 10.1097/fad.0000000000000088 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Adverse Drug Reaction Bulletin, 2026-06. Verfasst von Mia Noergaard und 4 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben.
Themen: Patientensicherheit, Kinderkrankenpflege
Abstract (Originalsprache)
Ciprofloxacin use in pediatric patients has raised concerns about musculoskeletal adverse events. We assessed the safety of ciprofloxacin in children aged 0–17 years in a systematic review and meta-analysis. We searched PubMed, Embase, and the Cochrane Library on 11 June 2021. We included randomized controlled trials of pediatric patients treated with oral or intravenous ciprofloxacin and compared with a comparator. We included all ciprofloxacin regimens except those involving concomitant drug use. Two authors independently selected studies, extracted data, and assessed risk of bias. The main outcomes were risk ratios (RRs) for musculoskeletal adverse events and adverse events. Eight studies met the inclusion criteria, including 1176 ciprofloxacin-exposed patients, and six studies contributed to the meta-analysis. The RR for musculoskeletal adverse events was 1.13 [95% confidence interval (CI) 0.85–1.51], and the RR for adverse events was 1.12 (95% CI 0.93–1.35). We graded the quality of evidence for both outcomes as very low. Based on this very low-certainty evidence, we found no significant increase in musculoskeletal adverse events in pediatric patients exposed to ciprofloxacin. Ciprofloxacin should therefore be considered when the benefits outweigh the risks, such as in severe infections or when bacterial resistance limits other treatment options. However, high-quality studies are needed before firm conclusions can be drawn.
Zitieren
APA
Noergaard, M., Gotfredsen, D. R., Eliasen, A., Händel, M. N., & Andersen, J. T. (2026). Exposure to ciprofloxacin and risk of musculoskeletal adverse events in children: a systematic review and meta-analysis of randomized controlled trials. Adverse Drug Reaction Bulletin, 358(1), 1391-1394. https://doi.org/10.1097/fad.0000000000000088
Vancouver
Noergaard M, Gotfredsen DR, Eliasen A, Händel MN, Andersen JT. Exposure to ciprofloxacin and risk of musculoskeletal adverse events in children: a systematic review and meta-analysis of randomized controlled trials. Adverse Drug Reaction Bulletin. 2026;358(1):1391-1394. doi:10.1097/fad.0000000000000088
BibTeX
@article{Noergaard2026,
author = {Noergaard, Mia and Gotfredsen, Ditte Resendal and Eliasen, Astrid and Händel, Mina Nicole and Andersen, Jon Trærup},
title = {Exposure to ciprofloxacin and risk of musculoskeletal adverse events in children: a systematic review and meta-analysis of randomized controlled trials},
journal = {Adverse Drug Reaction Bulletin},
year = {2026},
volume = {358},
number = {1},
pages = {1391--1394},
doi = {10.1097/fad.0000000000000088}
}
EUVIMED